米托坦辅助治疗肾上腺皮质癌——在不确定性中前行 - Suppr

Suppr

超能文献

Adjuvant mitotane for adrenocortical cancer--working through uncertainty.

作者信息

Terzolo M, Fassnacht M, Ciccone G, Allolio B, Berruti A

机构信息

Department of Clinical and Biological Sciences, Internal Medicine I, University ofTurin, Orbassano 10043, Italy.

出版信息

J Clin Endocrinol Metab. 2009 Jun;94(6):1879-80. doi: 10.1210/jc.2009-0120.

DOI:10.1210/jc.2009-0120

PMID:19494162

Abstract

摘要

相似文献

Adjuvant mitotane for adrenocortical cancer--working through uncertainty.

J Clin Endocrinol Metab. 2009 Jun;94(6):1879-80. doi: 10.1210/jc.2009-0120.

Adjuvant mitotane for adrenocortical cancer--a recurring controversy.

J Clin Endocrinol Metab. 2008 Oct;93(10):3730-2. doi: 10.1210/jc.2008-0579.

Adjuvant mitotane in adrenocortical carcinoma.

N Engl J Med. 2007 Sep 20;357(12):1258-9; author reply 1259.

Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma?

J Clin Endocrinol Metab. 1998 Sep;83(9):3100-3. doi: 10.1210/jcem.83.9.5113.

Contribution of Therapeutic Monitoring in the Assessment of Toxic Adverse Effects of Mitotane: a Case Report.

Therapie. 2015 Nov-Dec;70(6):545-6. doi: 10.2515/therapie/2015043. Epub 2015 Aug 4.

Adjuvant mitotane in adrenocortical carcinoma.

N Engl J Med. 2007 Sep 20;357(12):1257-8; author reply 1259.

Adjuvant mitotane in adrenocortical carcinoma.

N Engl J Med. 2007 Sep 20;357(12):1258; author reply 1259.

Adjuvant mitotane in adrenocortical carcinoma.

N Engl J Med. 2007 Sep 20;357(12):1256-7; author reply 1259. doi: 10.1056/NEJMc076267.

Adjuvant mitotane therapy of adrenal cancer - use and controversy.

N Engl J Med. 2007 Jun 7;356(23):2415-8. doi: 10.1056/NEJMe078087.

Practical treatment using mitotane for adrenocortical carcinoma.

Curr Opin Endocrinol Diabetes Obes. 2014 Jun;21(3):159-65. doi: 10.1097/MED.0000000000000056.

引用本文的文献

Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study.

Lancet Diabetes Endocrinol. 2023 Oct;11(10):720-730. doi: 10.1016/S2213-8587(23)00193-6. Epub 2023 Aug 21.

Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma.

J Clin Endocrinol Metab. 2014 Feb;99(2):455-61. doi: 10.1210/jc.2013-2856. Epub 2013 Dec 3.

Adrenocortical carcinoma: a clinician's update.

Nat Rev Endocrinol. 2011 Jun;7(6):323-35. doi: 10.1038/nrendo.2010.235. Epub 2011 Mar 8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Adjuvant mitotane for adrenocortical cancer--working through uncertainty.

J Clin Endocrinol Metab. 2009 Jun;94(6):1879-80. doi: 10.1210/jc.2009-0120.

Adjuvant mitotane for adrenocortical cancer--a recurring controversy.

J Clin Endocrinol Metab. 2008 Oct;93(10):3730-2. doi: 10.1210/jc.2008-0579.

Adjuvant mitotane in adrenocortical carcinoma.

N Engl J Med. 2007 Sep 20;357(12):1258-9; author reply 1259.

Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma?

J Clin Endocrinol Metab. 1998 Sep;83(9):3100-3. doi: 10.1210/jcem.83.9.5113.

Contribution of Therapeutic Monitoring in the Assessment of Toxic Adverse Effects of Mitotane: a Case Report.

Therapie. 2015 Nov-Dec;70(6):545-6. doi: 10.2515/therapie/2015043. Epub 2015 Aug 4.

Adjuvant mitotane in adrenocortical carcinoma.

N Engl J Med. 2007 Sep 20;357(12):1257-8; author reply 1259.

Adjuvant mitotane in adrenocortical carcinoma.

N Engl J Med. 2007 Sep 20;357(12):1258; author reply 1259.

Adjuvant mitotane in adrenocortical carcinoma.

N Engl J Med. 2007 Sep 20;357(12):1256-7; author reply 1259. doi: 10.1056/NEJMc076267.

Adjuvant mitotane therapy of adrenal cancer - use and controversy.

N Engl J Med. 2007 Jun 7;356(23):2415-8. doi: 10.1056/NEJMe078087.

Practical treatment using mitotane for adrenocortical carcinoma.

Curr Opin Endocrinol Diabetes Obes. 2014 Jun;21(3):159-65. doi: 10.1097/MED.0000000000000056.

引用本文的文献

Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study.

Lancet Diabetes Endocrinol. 2023 Oct;11(10):720-730. doi: 10.1016/S2213-8587(23)00193-6. Epub 2023 Aug 21.

Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma.

J Clin Endocrinol Metab. 2014 Feb;99(2):455-61. doi: 10.1210/jc.2013-2856. Epub 2013 Dec 3.

Adrenocortical carcinoma: a clinician's update.

Nat Rev Endocrinol. 2011 Jun;7(6):323-35. doi: 10.1038/nrendo.2010.235. Epub 2011 Mar 8.